Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3350508
Max Phase: Preclinical
Molecular Formula: C26H44IN8O16P3
Molecular Weight: 944.50
Molecule Type: Small molecule
Associated Items:
ID: ALA3350508
Max Phase: Preclinical
Molecular Formula: C26H44IN8O16P3
Molecular Weight: 944.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(CCCCN(C)C(=O)CCCNc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O)C(=O)CCCNC(=O)CI
Standard InChI: InChI=1S/C26H44IN8O16P3/c1-33(19(37)7-5-9-28-18(36)13-27)11-3-4-12-34(2)20(38)8-6-10-29-24-21-25(31-15-30-24)35(16-32-21)26-23(40)22(39)17(49-26)14-48-53(44,45)51-54(46,47)50-52(41,42)43/h15-17,22-23,26,39-40H,3-14H2,1-2H3,(H,28,36)(H,44,45)(H,46,47)(H,29,30,31)(H2,41,42,43)/t17-,22-,23-,26-/m1/s1
Standard InChI Key: ZPZHCUFLWKGJJT-VLYKXWEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 944.50 | Molecular Weight (Monoisotopic): 944.1133 | AlogP: 0.01 | #Rotatable Bonds: 23 |
Polar Surface Area: 334.86 | Molecular Species: ACID | HBA: 17 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.90 | CX Basic pKa: 4.74 | CX LogP: -5.20 | CX LogD: -10.33 |
Aromatic Rings: 2 | Heavy Atoms: 54 | QED Weighted: 0.03 | Np Likeness Score: 0.26 |
1. Hampton A, Patel AD, Chawla RR, Kappler F, Hai TT.. (1982) Use of adenine nucleotide derivatives to assess the potential of exo-active-site-directed reagents as species- or isozyme-specific enzyme inactivators. 5. Interactions of adenosine 5'-triphosphate derivatives with rat pyruvate kinases, Escherichia coli thymidine kinase, and yeast and rat hexokinases., 25 (4): [PMID:7040662] [10.1021/jm00346a011] |
Source(1):